Revolo Biotherapeutics is Drug Discovery in United Kingdom that focus on bowel diseases business. Founded in 2011. They cover business area such as developer, anti-inflammatory peptide, immuno-inflammatory disease, management, severe chronic inflammatory disease, disease modification, remission, patient, asthma, atopic dermatitis, inflammatory bowel disease, improved treatment, quick recovery.
2011
( 13 years old in 2024 )
Bowel Diseases
-
C/o BCS, Windsor House
Station Court, Station Road, Great Shelford
Cambridge CB22 5NE
England, United Kingdom
Private
developeranti-inflammatory peptideimmuno-inflammatory diseasemanagementsevere chronic inflammatory diseasedisease modificationremissionpatientasthmaatopic dermatitisinflammatory bowel diseaseimproved treatmentquick recovery
* We use standard office opening hours in near Revolo Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Revolo Biotherapeutics is Drug Discovery business from United Kingdom that founded in 2011 (13 years old in 2024), Revolo Biotherapeutics business is focusing on Bowel Diseases.
Revolo Biotherapeutics headquarter office and corporate office address is located in C/o BCS, Windsor House Station Court, Station Road, Great Shelford Cambridge CB22 5NE England, United Kingdom.
Revolo Biotherapeutics was founded in United Kingdom.
In 2024, Revolo Biotherapeutics is currently focus on bowel diseases sector.
Above is snippet of Google Trends for "bowel diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Revolo Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
